BioXcel Therapeutics, Inc. (BTAI) ownership: Top institutional holder: MILLENNIUM MANAGEMENT LLC ($2.60M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1936760.00 | $2.60M | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 1910076.00 | $2.56M | 2026-03-31 |
| VANGUARD GROUP INC | 292753.00 | $468405.00 | 2025-12-31 |
| OAKTREE CAPITAL MANAGEMENT LP | 241188.00 | $323193.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 230168.00 | $308725.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 207339.00 | $277834.00 | 2026-03-31 |
| JANE STREET GROUP, LLC | 127501.00 | $204002.00 | 2025-12-31 |
| GSA CAPITAL PARTNERS LLP | 120102.00 | $192000.00 | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 |
Back to BTAI overview · BTAI earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.